Form 4: Bicycle Therapeutics Director Pierre Legault Receives Stock Options and Restricted Stock Units

Director Pierre Legault of Bicycle Therapeutics PLC was granted stock options and restricted stock units, as detailed in a recent SEC filing.

Summary

• Pierre Legault, a director at Bicycle Therapeutics PLC, received 12,500 restricted stock units (RSUs) and options to purchase 25,000 ordinary shares on January 2, 2025.
• The RSUs and stock options vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025, and December 15, 2025.
• Each RSU represents a contingent right to receive one ordinary share.
• The stock options have an exercise price of $14 and expire on January 2, 2035.
• Following these transactions, Mr. Legault beneficially owns 46,000 ordinary shares.

Sentiment

Score: 7

Explanation: The document reflects a standard equity grant to a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The vesting of the RSUs and stock options is contingent on the director's continued service with the company.

Industry Context

Equity compensation is a common practice for incentivizing directors and executives in the biotechnology industry.

Comparison to Industry Standards

• The vesting schedule of the RSUs and stock options is typical for the industry, with quarterly vesting over a one-year period.
• The exercise price of $14 for the stock options is standard for grants to directors and executives.
• Companies like Amgen, Regeneron, and Gilead Sciences also use similar equity compensation plans for their directors and executives.

Stakeholder Impact

• Shareholders may view the equity grant positively as it aligns the director's interests with the company's long-term success.
• The grant does not have a direct impact on employees, customers, suppliers, or creditors.

Next Steps

• The RSUs and stock options will vest according to the schedule outlined in the document.
• The director may exercise the stock options at any time before their expiration date.

Key Dates

Keywords

Bicycle Therapeutics, Pierre Legault, stock options, restricted stock units, RSU, director, SEC Form 4, equity compensation, beneficial ownership